¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ Nw<P bklz  
SBfFZw)  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© 8k!6b\Imz  
k3hkk:W  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© v.g"{us  
X;GfPw.m  
1.Co-stimulators (or co-stimulating molecules) _6LoVS  
*e4TSqC|  
2.NK-kB $ |<m9CW  
(4+1lOd  
3.Immunoglobulin superfamily C7qYiSv  
ygViPz <J  
4.antigen-presenting cell (APC) AXW!]=?X  
D3]BTkMMS;  
5.death domain ')TPF{\#  
*HlDS22  
6.CCR and CXCR hnxc`VX>g  
!]b@RUU  
7.Lectin (or mitogen) #g v4  
nX5C< Ky  
8.Clusters of differentiation, CD) Ijo(^v@  
Z9 w:&oa@  
9.B7 family 8vD3=yK%^  
b|?;h21rG  
10.Cytotoxic T lymphocyte, CTL)  s>[{}7ca  
y-+G wa3  
11.IL-15 and IL-15 receptor (IL-15R) nX[;^v/  
}~I|t!GL  
12.MHC restriction '}{?AUDx  
>BoSw&T$Q  
13.Affinity-chromatography +{-]P\oc  
VifmZ;S@Y  
14.Cyctosprin A, CsA tOg=zXm   
q=0 pQ 1>  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) m|4LbWz  
z`#_F}v,m/  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© =vEkMJ Os  
h~UJCn zS  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 ,wK 1=7  
- 9&g[  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ 'JZ_  
A ,<@m2  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ O),I[kb  
W_JhNe  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©  1N.tQ^  
C*pLq5s  
ÃâÒßѧרҵ£º kI+b <$:D  
3B#!2|  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ NG)7G   
-\,VGudM}  
Ïû»¯ÄÚ¿Æ£º 3"tg+DncC  
SALCuo"L  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ jt% WPkY:  
cYD1~JX.  
ѪҺ²¡Ñ§×¨Òµ£º Ar5JP_M`E  
C->[$HcRa  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
5+2=? ÕýÈ·´ð°¸:7
°´"Ctrl+Enter"Ö±½ÓÌá½»